Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Code: ALLI-Auto-2J290

Report

November 2019

Pages:230

Allied Market Research

Description

Table of Content

Tables & Figures

Self-Monitoring Blood Glucose Devices Market Overview :

The global self-monitoring blood glucose devices market was valued at USD 7,768 million in 2017 and is projected to reach USD 10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025.

Diabetes is a clinical condition where the glucose level in the blood increases due to inability of the pancreas to produce insulin. Glucose monitoring is one of the essential steps toward diabetes management. Monitoring of blood glucose helps patients decide the amount of food intake, dosage of insulin, as well as type of physical exercise required for the day. Self-monitoring blood glucose (SMBG) is modern diabetes management procedure, which involves the use of blood glucose meters to check glucose levels and provide an accurate measure of capillary glucose concentrations. SMBG technology uses test strips, lancets, and blood glucose meters to achieve better long-term glycemic control.

Factors such as rise in prevalence of diabetes caused by rapid urbanization and sedentary lifestyle significantly drive the growth of the global self-monitoring blood glucose devices market. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster & safer diagnosis as well as treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices provide the glucose level reading as a range and do not measure the exact level of glucose in blood. Moreover, high cost of blood glucose measuring devices hinders the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and rise in awareness about diabetes monitoring devices are expected to offer lucrative opportunities to the market players.

The global self-monitoring blood glucose devices market is segmented based on product, application, end user, and region. Depending on product, the market is divided into test strips, lancets, and blood glucose meters. By application, the self-monitoring blood glucose devices market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end user, the market is classified into hospitals home settings, and diagnostic centers. Based on region, the self-monitoring blood glucose devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Self-Monitoring Blood Glucose Devices Market :

The study provides an in-depth analysis of the global self-monitoring blood glucose devices market along with the current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on the global & regional scale are provided.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Self-Monitoring Blood Glucose Devices Key market segments :

By Product

Test Strips
Lancets
Blood Glucose Meters

By Application

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

By End User

Hospitals
Home Settings
Diagnostic Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
Becton, Dickinson and Company
B. Braun Melsungen AG
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Medtronic plc
PHC Holdings Corporation
Sanofi
Terumo Corporation
Trividia Health, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

ARKRAY USA
Nova Biomedical
Bionime Corporation
Sinocare, Inc.
All Medicus Co., Ltd

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Benefits for Stakeholders

1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Market Share Analysis, 2017 (%)

3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase in the incidence rate of diabetes

3.4.1.2. Rise in geriatric population

3.4.1.3. Technological advancements in diabetes monitoring devices

3.4.1.4. Rise in risk factors that lead to diabetes

3.4.2. Restraints

3.4.2.1. Inaccurate results

3.4.3. Opportunity

3.4.3.1. Increase in awareness for diabetes monitoring devices

3.4.3.2. Untapped market opportunities in the developing regions

3.4.4. Impact analyses

CHAPTER 4: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. Test Strips

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Lancets

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Blood Glucose Meters

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

CHAPTER 5: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by revenue

5.2. Type 1 Diabetes

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Type 2 diabetes

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Gestational Diabetes

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

CHAPTER 6: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Home Settings

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Diagnostic Centers

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. North America market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. market size and forecast, by product

7.2.2.1.2. U.S. market size and forecast, by application

7.2.2.1.3. U.S. market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada market size and forecast, by product

7.2.2.2.2. Canada market size and forecast, by application

7.2.2.2.3. Canada market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico market size and forecast, by product

7.2.2.3.2. Mexico market size and forecast, by application

7.2.2.3.3. Mexico market size and forecast, by end user

7.2.3. North America market size and forecast, by product

7.2.4. North America market size and forecast, by application

7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Europe self-monitoring blood glucose devices market, by country

7.3.2.1. Germany

7.3.2.1.1. Germany market size and forecast, by product

7.3.2.1.2. Germany market size and forecast, by application

7.3.2.1.3. Germany market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France market size and forecast, by product

7.3.2.2.2. France market size and forecast, by application

7.3.2.2.3. France market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK market size and forecast, by product

7.3.2.3.2. UK market size and forecast, by application

7.3.2.3.3. UK market size and forecast, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy market size and forecast, by product

7.3.2.4.2. Italy market size and forecast, by application

7.3.2.4.3. Italy market size and forecast, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain market size and forecast, by product

7.3.2.5.2. Spain market size and forecast, by application

7.3.2.5.3. Spain market size and forecast, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe market size and forecast, by product

7.3.2.6.2. Rest of Europe market size and forecast, by application

7.3.2.6.3. Rest of Europe market size and forecast, by end user

7.3.3. Europe market size and forecast, by product

7.3.4. Europe market size and forecast, by application

7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan market size and forecast, by product

7.4.2.1.2. Japan market size and forecast, by application

7.4.2.1.3. Japan market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China market size and forecast, by product

7.4.2.2.2. China market size and forecast, by application

7.4.2.2.3. China market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India market size and forecast, by product

7.4.2.3.2. India market size and forecast, by application

7.4.2.3.3. India market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia market size and forecast, by product

7.4.2.4.2. Australia market size and forecast, by application

7.4.2.4.3. Australia market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea market size and forecast, by product

7.4.2.5.2. South Korea market size and forecast, by application

7.4.2.5.3. South Korea market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product

7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application

7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user

7.4.3. Asia-Pacific market size and forecast, by product

7.4.4. Asia-Pacific market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil market size and forecast, by product

7.5.2.1.2. Brazil market size and forecast, by application

7.5.2.1.3. Brazil market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia market size and forecast, by product

7.5.2.2.2. Saudi Arabia market size and forecast, by application

7.5.2.2.3. Saudi Arabia market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Arica market size and forecast, by product

7.5.2.3.2. South Arica market size and forecast, by application

7.5.2.3.3. South Arica market size and forecast, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA market size and forecast, by product

7.5.2.4.2. Rest of LAMEA market size and forecast, by application

7.5.2.4.3. Rest of LAMEA market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product

7.5.4. LAMEA market size and forecast, by application

7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product Portfolio

8.1.5. Business performance

8.1.6. Key strategic moves and developments

8.2. Becton, Dickinson and Company

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product Portfolio

8.2.5. Business performance

8.2.6. Key strategic moves and developments

8.3. B. Braun Melsungen AG

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product Portfolio

8.3.5. Business performance

8.3.6. Key strategic moves and developments

8.4. F. Hoffmann-La Roche Ltd.

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

8.5. Johnson & Johnson

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product Portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. Medtronic plc

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product Portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. PHC Holdings Corporation

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Key strategic moves and developments

8.8. Sanofi

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product Portfolio

8.8.5. Business performance

8.8.6. Key strategic moves and developments

8.9. Terumo Corporation

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product Portfolio

8.9.5. Business performance

8.10. Trividia Health, Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfoli

TABLE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 02. SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 03. SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 04. SELF-MONITORING BLOOD GLUCOSE METERS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 05. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 06. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 07. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 08. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 09. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)

TABLE 10. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, BY REGION, 2017-2025 ($MILLION)

TABLE 11. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, BY REGION, 2017-2025 ($MILLION)

TABLE 12. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2017-2025 ($MILLION)

TABLE 13. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 14. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 15. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 16. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 17. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 18. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 19. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 20. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 21. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 22. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 23. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 24. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 25. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 26. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 27. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 28. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 29. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 30. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 31. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 32. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 33. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 34. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 35. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 36. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 37. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 38. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 40. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 41. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 42. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 43. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 44. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 45. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 46. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 47. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 48. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 49. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 50. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 51. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 52. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 53. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 54. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 55. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 56. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 57. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 58. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 59. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 60. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 61. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 62. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 63. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 64. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 65. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 66. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 67. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 68. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 69. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 70. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 71. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 72. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 73. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 74. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 75. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 76. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 77. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 78. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 79. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 80. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 81. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 82. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 83. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 84. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 85. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 86. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 87. ABBOTT: COMPANY SNAPSHOT

TABLE 88. ABBOTT: OPERATING SEGMENTS

TABLE 89. ABBOTT: PRODUCT PORTFOLIO

TABLE 90. BD: COMPANY SNAPSHOT

TABLE 91. BD: BUSINESS SEGMENTS

TABLE 92. BD: PRODUCT PORTFOLIO

TABLE 93. B. BRAUN: COMPANY SNAPSHOT

TABLE 94. B. BRAUN: OPERATING SEGMENTS

TABLE 95. B. BRAUN: PRODUCT PORTFOLIO

TABLE 96. ROCHE: COMPANY SNAPSHOT

TABLE 97. ROCHE: OPERATING SEGMENTS

TABLE 98. ROCHE: PRODUCT PORTFOLIO

TABLE 99. J&J: COMPANY SNAPSHOT

TABLE 100. J&J: OPERATING SEGMENTS

TABLE 101. J&J: PRODUCT PORTFOLIO

TABLE 102. MEDTRONIC: COMPANY SNAPSHOT

TABLE 103. MEDTRONIC: OPERATING SEGMENTS

TABLE 104. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 105. PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT

TABLE 106. PHC HOLDINGS CORPORATION: BUSINESS SEGMENTS

TABLE 107. PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO

TABLE 108. SANOFI: COMPANY SNAPSHOT

TABLE 109. SANOFI: OPERATING SEGMENTS

TABLE 110. SANOFI: PRODUCT PORTFOLIO

TABLE 111. TERUMO: COMPANY SNAPSHOT

TABLE 112. TERUMO: OPERATING SEGMENTS

TABLE 113. TERUMO: PRODUCT PORTFOLIO

TABLE 114. TRIVIDIA HEALTH, INC.: COMPANY SNAPSHOT

TABLE 115. TRIVIDIA HEALTH, INC.: PRODUCT SEGMENTS

TABLE 116. TRIVIDIA HEALTH, INC.: PRODUCT PORTFOLIO FIGURE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2017*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2017* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2017*

FIGURE 06. MARKET SHARE ANALYSIS, 2017

FIGURE 07. PERCENTAGE OF POPULATION AGED 65 AND OVER ACROSS THE WORLD: 2015 AND 2050

FIGURE 08. IMPACT ANALYSES

FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET FOR BRACKETS, 2017 & 2025 (%)

FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, 2017 & 2025 (%)

FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE METERS MARKET, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, 2017 & 2025 (%)

FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, 2017 & 2025 (%)

FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, 2017 & 2025 (%)

FIGURE 18. ABBOTT: NET SALES, 2015-2017 ($MILLION)

FIGURE 19. ABBOTT: NET SALES SHARE BY SEGMENT, 2017 (%)

FIGURE 20. ABBOTT: NET SALES SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 21. BD: NET SALES, 2015-2017 ($MILLION)

FIGURE 22. BD: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 23. BD: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 24. NET SALES, 2015-2017 ($MILLION)

FIGURE 25. B. BRAUN: NET SALES BY SEGMENT, 2017 (%)

FIGURE 26. B. BRAUN: NET SALES BY GEOGRAPHY, 2017 (%)

FIGURE 27. ROCHE: NET SALES, 2015-2017 ($MILLION)

FIGURE 28. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 29. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 30. J&J: NET SALES, 2015-2017 ($MILLION)

FIGURE 31. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 32. J&J: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 33. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)

FIGURE 34. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)

FIGURE 35. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2017 (%)

FIGURE 36. SANOFI: NET SALES, 2015-2017 ($MILLION)

FIGURE 37. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 38. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 39. TERUMO: NET SALES, 2015-2017 ($MILLION)

FIGURE 40. TERUMO: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 41. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2017 (%

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5370

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$6450

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8995

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

Published Date: November 2019

Report Code: ALLI-Auto-2J290

Self-Monitoring Blood Glucose Devices Market Overview :

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions